Chelsea Drugs Inc
Pharmacy
44 Genesee St, New Hartford
New York, 13413
315-732-1615 315-732-3604
Chelsea Drugs Inc is a Pharmacy in New Hartford, New York. It is located at 44 Genesee St, New Hartford and it's customer support contact number is 315-732-1615. The authorized person of Chelsea Drugs Inc is Mr. Earl Robert Black Jr., RPH who is President Pharmacist of the pharmacy and his contact number is 315-737-1615. Active license number of Chelsea Drugs Inc is 026090 for Pharmacy in New York. Chelsea Drugs Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Chelsea Drugs Inc is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Chelsea Drugs Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Chelsea Drugs Inc |
| Type: | Pharmacy |
| Location: | 44 Genesee St, New Hartford,
New York, 13413 |
| Phone: | 315-732-1615 |
| Fax: | 315-732-3604 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Mr. Earl Robert Black Jr. |
| Credentials: | RPH |
| Position: | President Pharmacist |
| Contact Number: | 315-737-1615 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1306903935 |
| NPI Enumeration Date: | 02 Jan, 2007 |
| NPI Last Update On: | 15 Dec, 2008 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Chelsea Drugs Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacy | 026090 | New York | Primary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 3336612 | Other | | Nabp |
| 02522663 | Medicaid | New York | |
Medicare Enrollment:
Chelsea Drugs Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 5597973065 | O20100930032437 | Chelsea Drugs Inc | DME SUPPLIER - PHARMACY |
Products Available:
Chelsea Drugs Inc has following products available for sale under medicare.
| Products: |
|---|
| • Blood Glucose Monitors & Supplies: Non-mail Order | • Canes & Crutches |
| • Orthoses: Off-the-shelf | • Ostomy Supplies |
| • Surgical Dressings | • Urological Supplies |
| • Walkers | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 44 Genesee St,
New Hartford, New York |
| Zip: | 13413 |
| Phone Number: | 315-732-1615 |
| Fax Number: | 315-732-3604 |
Patients can reach Chelsea Drugs Inc at
44 Genesee St, New Hartford, New York or can
call on customer care at 315-732-1615.
Comments/ Reviews:
Read all the reviews posted for Chelsea Drugs Inc below. You may also share your own experience with Chelsea Drugs Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.